MedCap AB (OSTO:MCAP) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:MCAP MedCap AB OSTO:MCAP
81 GF Score
Price kr519.50
GF Value kr556.75
Valuation Fairly Valued
View Full Analysis

What is MedCap AB FFO per Share?

FFO per Share only applies to REITs.

OSTO:MCAP
81GF Score
MedCap AB OSTO:MCAP
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is MedCap AB (OSTO:MCAP) Overvalued in 2026?

Based on GuruFocus' analysis, MedCap AB stock appears to be undervalued. The current stock price of kr519.50 is trading 6.7% below its estimated GF Value™ of kr556.75. GuruFocus considers MedCap AB to be Fairly Valued.

Key valuation signals for OSTO:MCAP:

  • FFO per Share:
  • GF Value™: kr556.75 vs. price of kr519.50 (6.7% below fair value)
  • GF Score™: 81/100

No single metric tells the full story. See the OSTO:MCAP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MedCap AB Business Description

Other Exchanges MCAPs:UK61MA:Germany
Address Sundbybergsvagen 1, Solna, SWE, 171 73
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.
81GF Score

Get the complete analysis for OSTO:MCAP

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr519.50
Price
kr556.75
GF Value